Notify me when Broadwood Partners, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OCX | Oncocyte Corp | Common Stock, no par value | 40.2% | $32.1M | 11.6M | NEAL C. BRADSHER | Feb 6, 2025 | ||
| STAA | STAAR SURGICAL CO | Common Stock, par value $0.01 per share | 30.2% | $418M | $41.7M | 15M | +11.1% | Neal C. Bradsher | Nov 20, 2025 |
| LCTX | Lineage Cell Therapeutics, Inc. | Common shares | 23.1% | $97.8M | 57.8M | 0% | NEAL C. BRADSHER | Nov 12, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|